Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.94
+0.16 (1.44%)
Nov 9, 2026, 12:24 PM EST - Market open
Novavax Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,804 | 1,092 | 1,288 | 570 | 884 | 10,817 | |
Market Cap Growth | 44.47% | -15.21% | 125.87% | -35.49% | -91.83% | 165.21% |
Enterprise Value | 1,477 | 580 | 641 | 178 | 300 | 9,339 |
Last Close Price | 10.78 | 6.72 | 8.04 | 4.80 | 10.28 | 143.07 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 2.48 | - | - | - | - |
Forward PE | 22.73 | 8.33 | 28.96 | 3.15 | 3.15 | 10.46 |
PS Ratio | 4.32 | 0.97 | 1.89 | 0.58 | 0.45 | 9.44 |
PB Ratio | - | -8.55 | -2.06 | -0.79 | -1.39 | -30.76 |
P/FCF Ratio | - | - | - | - | - | 40.30 |
P/OCF Ratio | - | - | - | - | - | 33.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.53 | 0.52 | 0.94 | 0.18 | 0.15 | 8.15 |
EV/EBITDA Ratio | - | 0.98 | - | - | - | - |
EV/EBIT Ratio | - | 1.03 | - | - | - | - |
EV/FCF Ratio | - | - | - | - | - | 34.79 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -1.36 | -2.18 | -0.42 | -0.39 | -0.97 | -1.49 |
Debt / EBITDA Ratio | - | 0.46 | - | - | - | - |
Debt / FCF Ratio | - | - | - | - | - | 1.95 |
Net Debt / Equity Ratio | 1.51 | 3.58 | 1.06 | 0.40 | 1.14 | 2.82 |
Net Debt / EBITDA Ratio | 5.88 | -0.77 | 3.60 | 0.56 | 1.17 | 0.59 |
Net Debt / FCF Ratio | 1.35 | 1.83 | 6.58 | 0.38 | 1.43 | -3.69 |
Asset Turnover | 0.40 | 0.82 | 0.41 | 0.49 | 0.82 | 0.55 |
Inventory Turnover | 24.36 | 40.39 | 23.41 | 27.52 | 90.94 | - |
Quick Ratio | 2.04 | 1.83 | 0.89 | 0.53 | 0.58 | 0.82 |
Current Ratio | 2.15 | 2.13 | 0.98 | 0.70 | 0.69 | 0.90 |
Return on Equity (ROE) | - | - | - | - | - | -1265.71% |
Return on Assets (ROA) | -4.22% | 25.72% | -8.63% | -17.02% | -16.67% | -50.69% |
Return on Invested Capital (ROIC) | -11.81% | 99.92% | -81.62% | - | - | -577.12% |
Return on Capital Employed (ROCE) | -12.50% | 78.60% | -57.10% | -340.10% | 320.30% | -904.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.28% | 40.32% | -14.56% | -95.59% | -74.44% | -16.12% |
FCF Yield | -13.67% | -22.91% | -7.79% | -134.64% | -57.14% | 2.48% |
Buyback Yield / Dilution | 1.44% | -13.74% | -51.03% | -28.89% | -5.08% | -29.27% |